Merdad Parsey is Chief Medical Officer at GILEAD SCIENCES, INC. (GILD). They have made 3 open-market trades across 1 company since 2020, most recently 2026-06-16.
CIK 0001792150
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GILD | SELL | 2024-11-27 | 2024-11-29 | $91.88 | $20.6M | -0.2% | -0.6% | +21.0% |
| GILD | SELL · 10b5-1 | 2024-11-06 | 2024-11-07 | $91.50 | $2.3M | -8.6% | -5.7% | +3.7% |
| GILD | SELL · 10b5-1 | 2024-10-01 | 2024-10-02 | $83.83 | $168K | +0.9% | +6.2% | +9.6% |
| GILD | SELL · 10b5-1 | 2024-09-12 | 2024-09-13 | $84.50 | $1.8M | -1.0% | +2.5% | +11.3% |
| GILD | SELL · 10b5-1 | 2024-07-01 | 2024-07-01 | $68.63 | $137K | +2.4% | +11.4% | +22.8% |
| GILD | SELL · 10b5-1 | 2024-04-01 | 2024-04-02 | $72.96 | $146K | -5.5% | -9.3% | -4.7% |
| GILD | SELL · 10b5-1 | 2024-02-28 | 2024-02-29 | $72.79 | $1.3M | +3.9% | +0.8% | -12.1% |
| GILD | SELL · 10b5-1 | 2023-09-12 | 2023-09-13 | $76.99 | $231K | -2.6% | +1.1% | +5.2% |
| GILD | SELL · 10b5-1 | 2023-06-13 | 2023-06-14 | $76.90 | $228K | -2.9% | -1.4% | -1.9% |
| GILD | SELL | 2023-03-13 | 2023-03-14 | $78.99 | $968K | +1.1% | +5.3% | -1.6% |
| GILD | SELL | 2023-03-01 | 2023-03-02 | $79.96 | $2.1M | -0.1% | +4.3% | -3.6% |
| GILD | SELL · 10b5-1 | 2022-12-30 | 2023-01-03 | $85.33 | $47K | +0.1% | -5.6% | -3.4% |
| GILD | SELL · 10b5-1 | 2020-08-17 | 2020-08-19 | $68.32 | $12K | +1.4% | -1.2% | -7.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.